Submit your email to push it up the queue
Synovis Surgical Innovations, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in surgical solutions, particularly in the fields of soft tissue repair and regenerative medicine. With a focus on innovative products, Synovis offers a range of unique surgical implants and biomaterials designed to enhance patient outcomes. The company’s core offerings include advanced surgical meshes and grafts that are distinguished by their biocompatibility and effectiveness in promoting healing. Over the years, Synovis has achieved significant milestones, including recognition for its contributions to minimally invasive surgical techniques. With a strong market position, Synovis Surgical Innovations continues to drive advancements in surgical care, making a meaningful impact on the healthcare landscape.
How does Synovis Surgical Innovations, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Synovis Surgical Innovations, Inc.'s score of 39 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Synovis Surgical Innovations, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Baxter International Inc., which may influence its climate commitments and reporting practices. While Synovis Surgical Innovations has not established its own reduction targets or climate pledges, it is important to note that emissions data and performance metrics may be inherited from Baxter International Inc. at a cascade level of 2. This means that any climate initiatives or targets set by Baxter could potentially impact Synovis Surgical Innovations' environmental strategies. As of now, there are no documented reduction initiatives or commitments from Synovis Surgical Innovations, which suggests a need for further development in their climate action plans. The company operates within an industry increasingly focused on sustainability, and aligning with broader corporate climate goals could enhance its environmental performance in the future.
Access structured emissions data, company-specific emission factors, and source documents
2002 | 2003 | 2005 | 2006 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 781,365,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Synovis Surgical Innovations, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.